Business Strategy

More Topics
thumbnail
Seed Funding
Europe’s adversity to risk is why the US is ahead, say expertsEurope’s adversity to risk is why the US is ahead

Panelists at Bio Europe in Stockholm, Sweden debated whether culture is the main reason US average funding rounds are double that across the pond.

byMillie Nelson
Nov 5, 2024
|
1 Min Read
Picture with women's health written on a card in pink
Investment
Call for specific female health funding to tackle biotech finance gender gapCall for specific female health funding to tackle biotech finance gender gap
byMillie Nelson
Oct 30, 2024
1 Min Read
Webinar: Cracking the code - Mastering biopharma launches in Europe
Business Strategy
Cracking the code: Mastering biopharma launches in EuropeCracking the code: Mastering biopharma launches in Europe
Oct 24, 2024
thumbnail
Business Strategy
Build trust by making healthcare fairer and more equitable, say expertsBuild trust by making healthcare fairer and more equitable, say experts
byMillie Nelson
Oct 14, 2024
1 Min Read
Green leaf with sustainability symbol
Business Strategy
The sustainability series: Reflect, rethink, and reformThe sustainability series: Reflect, rethink, and reform
byMillie Nelson
Oct 11, 2024
1 Min Read
Overhead view of business people working and funding
Investment
$325 million Series C funding in its Arsenal (Biosciences)$325 million Series C funding in its Arsenal (Biosciences)
byMillie Nelson
Sep 25, 2024
1 Min Read
Christmas present
Partnering
RayzeBio: A Christmas to remember
RayzeBio: A Christmas to remember
Sep 25, 2024
|
1 Min Read
byMillie Nelson
Plenary at BIO-Europe in Munich
Investment
How industry trends are evolving biotech innovation in 2023
2023 industry trends that helped evolve biotech innovation
Sep 21, 2024
|
1 Min Read
photo of a hand holding a globe representing the environment.
Business Strategy
From aspiration to action: navigating sustainability in biopharma
Navigating sustainability in biopharma
Sep 19, 2024
|
1 Min Read
different coloured smoke
Business Strategy
Building successful teams in biotech: “The future is female and very colorful”
Building successful teams in biotech
May 7, 2024
|
1 Min Read
byMillie Nelson
CEO of Poseida, Kristin Yarema
Business Strategy
Poseida: New CEO, same passion for allogeneic therapies
Poseida: New CEO, same passion for allogeneic therapies
Feb 26, 2024
|
1 Min Read
byMillie Nelson
Sand timer
Business Strategy
Testing times: MilliporeSigma talks CDMO competition
Testing times: MilliporeSigma talks CDMO competition
Oct 11, 2023
|
1 Min Read
byMillie Nelson
Broken heart
Partnering
It’s not me, it’s you! Experts on when you should dump your CDMO
Experts on when you should dump your CDMO
Sep 22, 2023
|
1 Min Read
byMillie Nelson
Clinical Trials Word Cloud illustration
Innovation
Clinical trial innovation at BIO-Europe Spring 2023
Clinical trial innovation at BIO-Europe Spring 2023
Sep 21, 2023
|
1 Min Read
Note with politics written on it
Business Strategy
Patient access is political, say CGT experts
Patient access is political, say CGT experts
Jan 9, 2023
|
1 Min Read
byMillie Nelson

News from APAC

Money
Investment
Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blastEyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blast
byRichard Daverman
Nov 18, 2024
5 Min Read
Money
Investment
Eyes on Asia: Eyes on Asia: VC hits China, BioStar IPO, and Legend splits from GenScriptEyes on Asia: VC hits China, BioStar IPO, and Legend splits from GenScript
byRichard Daverman
Nov 5, 2024
3 Min Read
Reverse arrow
Partnering
Eddingpharm reverse-merger ‘breakthrough’ for Hong Kong stock exchangeEddingpharm reverse-merger ‘breakthrough’ for Hong Kong stock exchange
byRichard Daverman
Oct 31, 2024
3 Min Read

Recommended

Partnering
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Novo’s hunt for genetic med tech drove $600m NanoVation pact
Plenary at BIO-Europe in Munich
Investment
How industry trends are evolving biotech innovation in 2023
2023 industry trends that helped evolve biotech innovation
three member panel on stage
Innovation
‘Data matters most’ in biotech, and AI is here to help
‘Data matters most’ in biotech, and AI is here to help
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated